<!--?xml version="1.0" encoding="utf-8"?--><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="plosone"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3929651/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929651/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="PLoS ONE"><meta name="citation_title" content="Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis"><meta name="citation_authors" content="Roland Amathieu, Mohamed N. Triba, Pierre Nahon, Nadia Bouchemal, Walid Kamoun, Hakim Haouache, Jean-Claude Trinchet, Philippe Savarin, Laurence Le Moyec, Gilles Dhonneur"><meta name="citation_date" content="2014"><meta name="citation_issue" content="2"><meta name="citation_volume" content="9"><meta name="citation_doi" content="10.1371/journal.pone.0089230"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3929651/?report=abstract"><meta name="citation_pmid" content="24586615"><meta name="DC.Title" content="Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Public Library of Science"><meta name="DC.Contributor" content="Roland Amathieu"><meta name="DC.Contributor" content="Mohamed N. Triba"><meta name="DC.Contributor" content="Pierre Nahon"><meta name="DC.Contributor" content="Nadia Bouchemal"><meta name="DC.Contributor" content="Walid Kamoun"><meta name="DC.Contributor" content="Hakim Haouache"><meta name="DC.Contributor" content="Jean-Claude Trinchet"><meta name="DC.Contributor" content="Philippe Savarin"><meta name="DC.Contributor" content="Laurence Le Moyec"><meta name="DC.Contributor" content="Gilles Dhonneur"><meta name="DC.Date" content="2014"><meta name="DC.Identifier" content="10.1371/journal.pone.0089230"><meta name="DC.Language" content="en"><meta property="og:title" content="Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis"><meta property="og:type" content="article"><meta property="og:description" content="Acute-on-chronic liver failure is characterized by acute deterioration of liver function in patients with compensated or decompensated, but stable, cirrhosis. However, there is no accurate definition of acute-on-chronic liver failure and physicians often ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929651/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3929651/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3929651/pdf/pone.0089230.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1B7E65E8E3E98100000000039F039F.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.ncbi-alerts { background: none repeat scroll 0% 0% #671414;color: #fff;padding: .231em 1.231em;}.ncbi-alerts p { color: #fff; }.ncbi-alerts a, .ncbi-alerts a:visited {color: #fff; background: none;}.ncbi-alerts p {margin: 1em 0;padding: 0 0 0 1.5em; }.ncbi-alerts p:nth-child(1) {background-image: url('/core/icons/information.png');background-position: left top;background-repeat: no-repeat }.ncbi-alerts.subclosed p:nth-child(1) {background-image: url('/core/alerts/warning.png');}.ncbi-alerts.subclosed p { padding-left: 2em;}.ncbi-alerts.pubmed, .ncbi-alerts.pubmed p {background-color: #97B0C8; color: #000;}.ncbi-alerts a { text-decoration: underline !important; }.ncbi-alerts.pubmed a, .ncbi-alerts.pubmed a:visited { color: #000; }.ncbi-alerts, .ncbi-alerts p {background-color: #97B0C8; color: #000;}.ncbi-alerts a, .ncbi-alerts a:visited { color: #000; }</style></head>
    <body class="article" id="ui-ncbiexternallink-3">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3929651%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header" style="margin-bottom: 0px;">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/233283/">v.9(2); 2014</a></li><li class="accid">PMC3929651</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0089230" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">PLoS One</a></span>. 2014; 9(2): e89230. </span></div><div><span class="fm-vol-iss-date">Published online 2014 Feb 19. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1371%2Fjournal.pone.0089230" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0089230</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3929651</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/24586615">24586615</a></div></div></div></div><h1 class="content-title">Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Amathieu%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814058684288" co-class="co-affbox">Roland Amathieu</a>,<sup>#</sup><sup>
1
,</sup><sup>
2
,</sup><sup>
*
</sup> <a href="/pubmed/?term=Triba%20MN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814059114000" co-class="co-affbox">Mohamed N. Triba</a>,<sup>#</sup><sup>
2
</sup> <a href="/pubmed/?term=Nahon%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814059111952" co-class="co-affbox">Pierre Nahon</a>,<sup>
3
</sup> <a href="/pubmed/?term=Bouchemal%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814062187200" co-class="co-affbox">Nadia Bouchemal</a>,<sup>
2
</sup> <a href="/pubmed/?term=Kamoun%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814052091008" co-class="co-affbox">Walid Kamoun</a>,<sup>
1
</sup> <a href="/pubmed/?term=Haouache%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814059902704" co-class="co-affbox">Hakim Haouache</a>,<sup>
1
</sup> <a href="/pubmed/?term=Trinchet%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814100834048" co-class="co-affbox">Jean-Claude Trinchet</a>,<sup>
3
</sup> <a href="/pubmed/?term=Savarin%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814100963008" co-class="co-affbox">Philippe Savarin</a>,<sup>
2
</sup> <a href="/pubmed/?term=Le%20Moyec%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814100960752" co-class="co-affbox">Laurence Le Moyec</a>,<sup>
4
</sup> and  <a href="/pubmed/?term=Dhonneur%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615" class="affpopup" co-rid="_co_idm139814060416896" co-class="co-affbox">Gilles Dhonneur</a><sup>
1
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139814058684288"><h3 class="no_margin">Roland Amathieu</h3><p>  <sup>1</sup>  Service d’Anesthésie et des Réanimations Chirurgicales, Université Paris 12, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), Créteil, France,   </p><p>  <sup>2</sup>  Universite Paris 13, Sorbonne Paris Cité, Laboratoire Chimie, Structures, Propriétés de Biomatériaux et d’Agents Thérapeutiques (CSPBAT), Unité Mixte de Recherche (UMR) 7244, Centre National de Recherche Scientifique (CNRS), Equipe Spectroscopie des Biomolécules et des Milieux Biologiques (SBMB), Bobigny, France,   </p><div>Find articles by <a href="/pubmed/?term=Amathieu%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Roland Amathieu</a></div></div><div id="_co_idm139814059114000"><h3 class="no_margin">Mohamed N. Triba</h3><p>  <sup>2</sup>  Universite Paris 13, Sorbonne Paris Cité, Laboratoire Chimie, Structures, Propriétés de Biomatériaux et d’Agents Thérapeutiques (CSPBAT), Unité Mixte de Recherche (UMR) 7244, Centre National de Recherche Scientifique (CNRS), Equipe Spectroscopie des Biomolécules et des Milieux Biologiques (SBMB), Bobigny, France,   </p><div>Find articles by <a href="/pubmed/?term=Triba%20MN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Mohamed N. Triba</a></div></div><div id="_co_idm139814059111952"><h3 class="no_margin">Pierre Nahon</h3><p>  <sup>3</sup>  Service d’Hépatologie et Université Paris 13, Hôpital Jean Verdier, Assistance Publique des Hôpitaux de Paris (AP-HP), Bondy, France,   </p><div>Find articles by <a href="/pubmed/?term=Nahon%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Pierre Nahon</a></div></div><div id="_co_idm139814062187200"><h3 class="no_margin">Nadia Bouchemal</h3><p>  <sup>2</sup>  Universite Paris 13, Sorbonne Paris Cité, Laboratoire Chimie, Structures, Propriétés de Biomatériaux et d’Agents Thérapeutiques (CSPBAT), Unité Mixte de Recherche (UMR) 7244, Centre National de Recherche Scientifique (CNRS), Equipe Spectroscopie des Biomolécules et des Milieux Biologiques (SBMB), Bobigny, France,   </p><div>Find articles by <a href="/pubmed/?term=Bouchemal%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Nadia Bouchemal</a></div></div><div id="_co_idm139814052091008"><h3 class="no_margin">Walid Kamoun</h3><p>  <sup>1</sup>  Service d’Anesthésie et des Réanimations Chirurgicales, Université Paris 12, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), Créteil, France,   </p><div>Find articles by <a href="/pubmed/?term=Kamoun%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Walid Kamoun</a></div></div><div id="_co_idm139814059902704"><h3 class="no_margin">Hakim Haouache</h3><p>  <sup>1</sup>  Service d’Anesthésie et des Réanimations Chirurgicales, Université Paris 12, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), Créteil, France,   </p><div>Find articles by <a href="/pubmed/?term=Haouache%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Hakim Haouache</a></div></div><div id="_co_idm139814100834048"><h3 class="no_margin">Jean-Claude Trinchet</h3><p>  <sup>3</sup>  Service d’Hépatologie et Université Paris 13, Hôpital Jean Verdier, Assistance Publique des Hôpitaux de Paris (AP-HP), Bondy, France,   </p><div>Find articles by <a href="/pubmed/?term=Trinchet%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Jean-Claude Trinchet</a></div></div><div id="_co_idm139814100963008"><h3 class="no_margin">Philippe Savarin</h3><p>  <sup>2</sup>  Universite Paris 13, Sorbonne Paris Cité, Laboratoire Chimie, Structures, Propriétés de Biomatériaux et d’Agents Thérapeutiques (CSPBAT), Unité Mixte de Recherche (UMR) 7244, Centre National de Recherche Scientifique (CNRS), Equipe Spectroscopie des Biomolécules et des Milieux Biologiques (SBMB), Bobigny, France,   </p><div>Find articles by <a href="/pubmed/?term=Savarin%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Philippe Savarin</a></div></div><div id="_co_idm139814100960752"><h3 class="no_margin">Laurence Le Moyec</h3><p>  <sup>4</sup>  Institut National de la Santé et de la Recherche Médicale (INSERM) Unité de Biologie Intégrative des Adaptations à l’Exercice (UBIAE U902), Université d’Evry, Evry, France,   </p><div>Find articles by <a href="/pubmed/?term=Le%20Moyec%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Laurence Le Moyec</a></div></div><div id="_co_idm139814060416896"><h3 class="no_margin">Gilles Dhonneur</h3><p>  <sup>1</sup>  Service d’Anesthésie et des Réanimations Chirurgicales, Université Paris 12, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), Créteil, France,   </p><div>Find articles by <a href="/pubmed/?term=Dhonneur%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24586615">Gilles Dhonneur</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Petras Dzeja, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139814058824832_ai idm139814058684416_ai idm139814057793424_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139814058824832_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139814058824832_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139814058824832_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Service d’Anesthésie et des Réanimations Chirurgicales, Université Paris 12, Hôpital Henri Mondor, Assistance Publique des Hôpitaux de Paris (AP-HP), Créteil, France,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Universite Paris 13, Sorbonne Paris Cité, Laboratoire Chimie, Structures, Propriétés de Biomatériaux et d’Agents Thérapeutiques (CSPBAT), Unité Mixte de Recherche (UMR) 7244, Centre National de Recherche Scientifique (CNRS), Equipe Spectroscopie des Biomolécules et des Milieux Biologiques (SBMB), Bobigny, France,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  Service d’Hépatologie et Université Paris 13, Hôpital Jean Verdier, Assistance Publique des Hôpitaux de Paris (AP-HP), Bondy, France,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  Institut National de la Santé et de la Recherche Médicale (INSERM) Unité de Biologie Intégrative des Adaptations à l’Exercice (UBIAE U902), Université d’Evry, Evry, France,   </div><div class="fm-affl" lang="en" id="edit1">  Mayo Clinic, United States of America,   </div><div><sup>#</sup>Contributed equally.</div><div id="cor1">* E-mail: <a href="mailto:dev@null" data-email="rf.phpa.nmh@ueihtama.dnalor" class="oemail">rf.phpa.nmh@ueihtama.dnalor</a></div><div id="idm139814059810512"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</div><div><p id="__p2" class="p p-first-last">Conceived and designed the experiments: RA MNT PN LLM. Performed the experiments: RA MNT HH WK NB LLM. Analyzed the data: RA MNT LLM NB. Contributed reagents/materials/analysis tools: RA MNT LLM NB PS GD JCT. Wrote the paper: RA MNT LLM PN GD JCT.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139814058824832_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2013 Oct 18; Accepted 2014 Jan 17.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139814058824832_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2014 Amathieu et al</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3929651/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139814060350832" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139814060350832title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Introduction</h3><p id="__p3" class="p p-first-last">Acute-on-chronic liver failure is characterized by acute deterioration of liver function in patients with compensated or decompensated, but stable, cirrhosis. However, there is no accurate definition of acute-on-chronic liver failure and physicians often use this term to describe different clinical entities. Metabolomics investigates metabolic changes in biological systems and identifies the biomarkers or metabolic profiles. Our study assessed the metabolomic profile of serum using proton nuclear magnetic resonance (<sup>1</sup>H-NMR) spectroscopy to identify metabolic changes related to acute-on-chronic liver failure.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Patients</h3><p id="__p4" class="p p-first-last">Ninety-three patients with compensated or decompensated cirrhosis (CLF group) but stable liver function and 30 patients with cirrhosis and hospitalized for the management of an acute event who may be responsible of acute-on-chronic liver failure (ACLF group), were fully analyzed. Blood samples were drawn at admission, and sera were separated and stored at –80°C until <sup>1</sup>H-NMR spectral analysis. Using orthogonal projection to latent-structure discriminant analyses, various metabolites contribute to the complete separation between these both groups.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p5" class="p p-first-last">The predictability of the model was 0.73 (Q<sup>2</sup>
<em>Y</em>) and the explained variance was 0.63 (R<sup>2</sup>
<em>Y</em>). The main metabolites that had increased signals related to acute-on-chronic liver failure were lactate, pyruvate, ketone bodies, glutamine, phenylalanine, tyrosine, and creatinine. High-density lipids were lower in the ALCF group than in CLF group.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p6" class="p p-first-last">A serum metabolite fingerprint for acute-on-chronic liver failure, obtained with <sup>1</sup>H-NMR, was identified. Metabolomic profiling may aid clinical evaluation of patients with cirrhosis admitted into intensive care units with acute-on-chronic liver failure, and provide new insights into the metabolic processes involved in acute impairment of hepatic function.</p></div></div></div><div id="s1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s1title">Introduction</h2><p id="__p7" class="p p-first">Acute-on-chronic liver failure (ACLF) is a syndrome characterized by acute deterioration of liver function in patients with compensated or decompensated, though stable, cirrhosis. ACLF is a serious condition that has varied etiologies and manifestations, as well as a high mortality rate <a href="#pone.0089230-Olson1" rid="pone.0089230-Olson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269761" role="button" aria-expanded="false" aria-haspopup="true">[1]</a>. ACLF commonly occurs after an acute event, and is often associated with extra-hepatic organ failure. The most common triggers for ACLF include sepsis and digestive bleeding <a href="#pone.0089230-Jalan1" rid="pone.0089230-Jalan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269742" role="button" aria-expanded="false" aria-haspopup="true">[2]</a>. Any patient with cirrhosis is exposed to acute complications, which, in turn, may occasionally initiate a cascade of events that can lead to further deterioration of liver function, multiple-organ failure, and death within a few days or weeks. These patients with cirrhosis need ICU management.</p><p id="__p8">There is no consistent or clear definition of ACLF in the literature, and physicians often use this term to describe different conditions. Previous studies on ACLF have used different definitions, and there is no overall consensus for the liver failure that occurs, for the causative acute event, or for the diagnosis of the underlying chronic liver disease. Recently, the Asia-Pacific Association for the study of liver disease and the EASL-CLIF consortium have proposed different consensus definition for ACLF <a href="#pone.0089230-Moreau1" rid="pone.0089230-Moreau1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269752" role="button" aria-expanded="false" aria-haspopup="true">[3]</a>, <a href="#pone.0089230-Sarin1" rid="pone.0089230-Sarin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269760" role="button" aria-expanded="false" aria-haspopup="true">[4]</a>. In the Asiatic consensus, criteria for defining ACLF vary widely from the level of bilirubin, to the time until deterioration after onset, to an initiating event that is accepted as jaundice, or to any other symptom that pertains to hepatic dysfunction. In the EASL-CLIF consensus, patients with acute decompensated cirrhosis were classified in three grades according to renal impairment and/or others extra-hepatic organ failures.</p><p id="__p9">A better definition of ACLF could be obtained using new biomarkers. Nevertheless, it is now widely accepted that the search for a single biomarker that can be used in routine clinical practice to diagnosis patients with ACLF is probably unrealistic.</p><p id="__p10">Metabolomics, which is the study of metabolic changes in an integrated biological system using multiparametric analyses, may help identify biomarkers that characterize the metabolic profiles of a disease, and/or evaluate metabolic modifications after treatment has been initiated <a href="#pone.0089230-Dunn1" rid="pone.0089230-Dunn1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269749" role="button" aria-expanded="false" aria-haspopup="true">[5]</a>. Metabolomics, using proton nuclear magnetic resonance (<sup>1</sup>H-NMR) spectroscopy, when applied to liver disease, has shown a close relationship between metabolic abnormalities and the severity of the disease in sera and tissues <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269772" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>, <a href="#pone.0089230-MartinezGranados1" rid="pone.0089230-MartinezGranados1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269771" role="button" aria-expanded="false" aria-haspopup="true">[7]</a>, <a href="#pone.0089230-Yu1" rid="pone.0089230-Yu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269759" role="button" aria-expanded="false" aria-haspopup="true">[8]</a>.</p><p id="__p11">Jimenez <em>et al.</em> have shown that using <sup>1</sup>H-NMR to assess the metabolomics of sera from patients with cirrhosis could discriminate between patients with minimal hepatic encephalopathy and those with no encephalopathy <a href="#pone.0089230-Jimenez1" rid="pone.0089230-Jimenez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269745" role="button" aria-expanded="false" aria-haspopup="true">[9]</a>. Other studies show that metabolomics can fingerprint the differences between compensated and decompensated cirrhosis, and between cirrhosis caused by alcohol or viruses <a href="#pone.0089230-Qi1" rid="pone.0089230-Qi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269758" role="button" aria-expanded="false" aria-haspopup="true">[10]</a>, <a href="#pone.0089230-Qi2" rid="pone.0089230-Qi2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269757" role="button" aria-expanded="false" aria-haspopup="true">[11]</a>. We have previously shown that a metabolomic approach was a powerful tool in assessing the severity of chronic liver failure in alcohol-induced cirrhosis within a cohort of patients without ACLF. In our previous study, the severity of chronic liver failure was evaluated using the MELD score, and correlated well with impairment of lipid, glucose, and amino acid metabolism <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269767" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>.</p><p id="__p12">In ICU investigations of liver disease, some studies have evaluated the different metabolic profiles after transplantation and have compared non-survivor to survivor or graft-failure cases: they have shown improvement in patients’ liver status after transplantation <a href="#pone.0089230-Tripathi1" rid="pone.0089230-Tripathi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269744" role="button" aria-expanded="false" aria-haspopup="true">[12]</a>, <a href="#pone.0089230-Serkova1" rid="pone.0089230-Serkova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269753" role="button" aria-expanded="false" aria-haspopup="true">[13]</a>. Another study that assessed sera using <sup>1</sup>H-NMR showed the potential of the metabolomic profile to evaluate patients with fulminant hepatic failure and to predict an unfavorable outcome <a href="#pone.0089230-Saxena1" rid="pone.0089230-Saxena1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269768" role="button" aria-expanded="false" aria-haspopup="true">[14]</a>. However, none of these studies have focused on the changes in metabolism that occur in patients with cirrhosis and ACLF.</p><p id="__p13" class="p p-last">We hypothesize that patients with cirrhosis and hospitalized in ICUs have acute changes to their metabolism that can be identified using <sup>1</sup>H-NMR to evaluate their sera. These metabolic changes could then identify patients with ACLF, independently of trigger events. Thus, the purpose of our study was to assess whether the metabolomic profiles of sera, obtained by <sup>1</sup>H-NMR spectroscopy, were modified in patients with alcohol-induced cirrhosis and hospitalized in an ICU for an acute event known to cause ACLF, when compared to patients with compensated or decompensated, but stable, cirrhosis. Another aim was to identify the impaired common metabolic pathways. Consequently, the decrease or the increase of the different metabolic pathways will be discussed.</p></div><div id="s2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Patients and Collection of Sera Samples</h3><p id="__p14" class="p p-first">Between August 2010 and December 2010, all consecutive patients with cirrhosis and referred to our Liver Center were screened for the study. Unstable cirrhotic patients with high risk of liver and/or other organ failure secondary to a severe acute event, mainly gastrointestinal bleeding (GIB) or sepsis, hospitalized and managed in ICU were included in the ACLF group. Asian or EASL-CLIF consortium definitions were not used to include patient in ACLF group. Compensated and decompensated patients who had stable cirrhosis, and who had been referred to the hepatology unit, within the same period, for either therapeutic management (paracenthesis) or a screening procedure were included in the CLF group.</p><p id="__p15">Cirrhosis was defined by a liver biopsy or the presence of at least two compatible diagnostic factors from the following: radiology (ultrasound, computed tomography, or magnetic-resonance imaging), clinical examinations (at least two indicators: hepatomegaly, splenomegaly, encephalopathy, at least two arterial spiders, collateral venous circulation, or jaundice), and/or biological factors (increased bilirubinemia, a prolonged International Normalized Ratio, or thrombocytopenia).</p><p id="__p16">Only patients with alcoholic cirrhosis were considered. Exclusion criteria were infection with the human immunodeficiency virus, hepatitis B or C viruses, evidence of hepatocarcinoma (as judged by ultrasonographic findings and serum α-fetoprotein concentration &gt;50 ng/mL), and a past history of acute decompensation during the previous 6 months.</p><p id="__p17">The date of inclusion into the study was the date when blood was collected. Blood samples were drawn under fasting conditions for the CLF group and immediately at admission for the ALCF group. Serum was separated and stored at –80°C until further analyses. Gender, age, the presence of ascites or hepatic encephalopathy, serum bilirubin, albumin and prothrombin levels, the International Normalized Ratio, serum alanine-aminotransferase (ALT) activity, serum aspartate-aminotransferase (AST) activity, creatininemia, and platelet counts, were recorded at inclusion.</p><p id="__p18" class="p p-last">For patients with ALCF, diagnosis was made as they entered the ICU ward. The main diagnoses were sepsis, GIB, acute renal failure, or hepatic encephalopathy. Gastrointestinal bleeding was defined as any hematemesis or melena with transfusion of two or more units of blood. Sepsis was defined as proposed in the International Survey Sepsis Campaign <a href="#pone.0089230-Dellinger1" rid="pone.0089230-Dellinger1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269746" role="button" aria-expanded="false" aria-haspopup="true">[15]</a>. Blood lactate, hemodynamic parameters, and the use of catecholamine and mechanical ventilation were recorded. To evaluate the severity of the disease, the Sequential Organ Failure Assessment (SOFA) score was calculated during the first day of admission <a href="#pone.0089230-Vincent1" rid="pone.0089230-Vincent1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269763" role="button" aria-expanded="false" aria-haspopup="true">[16]</a>. For all patients, the severity of chronic liver failure was calculated using both the Child–Pugh–Turcott and MELD scores <a href="#pone.0089230-Pugh1" rid="pone.0089230-Pugh1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269764" role="button" aria-expanded="false" aria-haspopup="true">[17]</a>, <a href="#pone.0089230-Kamath1" rid="pone.0089230-Kamath1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269740" role="button" aria-expanded="false" aria-haspopup="true">[18]</a>. For the ACLF group, the more recent Child–Pugh–Turcott score before hospitalization in the ICU was taken into account.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Ethics Statement</h3><p id="__p19" class="p p-first-last">The Institutional Review Board of Jean Verdier University Hospital approved the protocol and the French Research Delegation Office accepted the creation of a dedicated bio-collection for the patients included in the protocol. The CNIL (National Informatics and Liberty Commission) also approved the creation of both bio-collection and database. Depending of the site of hospitalization (ward or ICU) and the mental status of the patient, the written consent was obtained directly from the patient at inclusion or from the Person of Confidence designed by the patient (pre-emptively) or by the family relatives. In case, the patient survived, secondary written consent from the patient was systematically seek.</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">
<sup>1</sup>H-NMR Spectroscopy</h3><p id="__p20" class="p p-first">For NMR analysis, samples were thawed at room temperature. A volume of 0.6 mL of serum was placed into a 5-mm-diameter tube together with 0.1 mL of D<sub>2</sub>O, which contained a known amount of fumaric acid. The proton spectra were acquired at 500 MHz on a Varian Unity Inova® spectrometer at 25°C. The signal was acquired after a 90° pulse on 32-K data points for a spectral window of 5000 Hz. The relaxation delay was 4 s. The water signal was suppressed by a pre-saturation sequence using low-power irradiation (0.03 W for 2 s) on the water-signal frequency during the relaxation delay. The Carr-Purcell-Meiboom-Gill (CPMG) sequence is frequently used by others <a href="#pone.0089230-Jimenez1" rid="pone.0089230-Jimenez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269766" role="button" aria-expanded="false" aria-haspopup="true">[9]</a> to suppress the broad protein signal according to its short T2 relaxation time. Because lipids content in the sera of patients with cirrhosis <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269741" role="button" aria-expanded="false" aria-haspopup="true">[6]</a> are an important discriminant variable, a single pulse sequence was preferred to preserve the complete lipid profile of the spectra. The resulting free induction decays obtained with 128 transients were processed by Mestrec® software.</p><p id="__p21">A Fourier transformation was applied with an exponential window function to produce a 1-Hz broadening line. The spectra were phased and a spline baseline correction was applied with three points at 0.5, 4.6, and 9 ppm. The chemical shifts were referenced using the fumaric-acid signal (6.53 ppm). The spectral region between 0–9 ppm was divided into 9000 spectral regions of 0.001-ppm width, called buckets, using a personal program with R®. Water, urea (signal damaged by water-saturation transfer), and fumaric-acid regions were excluded (1810 variables excluded).</p><p id="__p22" class="p p-last">At admission, ICU patients were not fasted whereas patients from the CLF group were. Moreover, some ICU patients were perfused with hydroxyl-ethyl starch, a volume expender, before admission to the ICU. Glucose residues of hydroxyl-ethyl starch produce an intense and broad resonance between 3.35 and 4.06 ppm. For this reason, the region between 3.35 and 4.06 ppm, corresponding to the glucose signal, was excluded from all spectra of the CLF and ACLF groups. Each bucket integral was integrated and scaled to the total summed bucket integrals for each spectrum.</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Demographic and Biological Analyses of Data</h3><p id="__p23" class="p p-first-last">Qualitative variables were compared using Fischer’s exact, chi-squared test or the chi-squared trend test with 1 degree of freedom, whereas quantitative variables were compared using the non-parametric Wilcoxon’s test. All reported <em>p</em> values are two-tailed. Associations were considered to be statistically significant at two-tailed α-values of 0.05.</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Multivariate Analyses</h3><p id="__p24" class="p p-first">A principal component analysis (PCA) was first performed to detect any group separation based on NMR-signal variability. This method also enabled detection and exclusion of any outliers, defined as observations located outside the 95% confidence region of the model. Orthogonal projection to latent-structure (OPLS) analysis was run to identify differences between patients in the CLF and ACLF groups. Compared to the classical projection of latent-structure analysis, this method allowed improved interpretation of the spectroscopic variations between the groups, by removing information that had no impact on the differences. PCA and OPLS analyses were performed using Simca-P12 (Umetrics, Umea) and in-house Matlab® (Mathworks, Natick, MA) code based on the Trygg and Wold method <a href="#pone.0089230-Trygg1" rid="pone.0089230-Trygg1" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">[19]</a>.</p><p id="__p25">The goodness-of-fit parameters for the OPLS model, <em>R</em>
<sup>2</sup>Yand <em>Q</em>
<sup>2</sup>Y, were calculated. <em>R</em>
<sup>2</sup>Y represents the explained variance of the Y matrix. <em>Q</em>
<sup>2</sup>Y estimates the predictability of the model. <em>R</em>
<sup>2</sup>Y = 1 indicates perfect description of the data by the model, whereas <em>Q</em>
<sup>2</sup>Y = 1 indicates perfect predictability. For internal validation of the OPLS models, a permutation test (999 permutations) was performed. This evaluated whether the OPLS models, built with the groups, was significantly better than any other OPLS model obtained by randomly permuting the original group attributes.</p><p id="__p26">A score plot illustrated the results. Each point in the score-plot represents the projection of an NMR spectrum (and thus a patient’s sample) on the predictive (horizontal axis) and the first orthogonal component of the model (vertical axis). The loading plot represents the covariance between the Y-response matrix and the signal intensity of the various spectral domains. Colors were also used in the loading plot depending of the <em>p-</em>value associated with the correlation between the corresponding bucket intensity and Y variable.</p><p id="__p27" class="p p-last">The null hypothesis associated with the <em>p</em>-values used in this study was that there was no correlation between X (intensity of the buckets) and Y (CLF or ALCF group) variables. To minimize false-positive rates in multiple comparisons of the 4239 spectral domains, we used the conservative Bonferroni correction, which discards any low significant variables. Thus, for an error rate of 0.01, a metabolite variation in the loading plot was considered significant if its <em>p-</em>value was less 2.4×10<sup>–6</sup>.</p></div><div id="s2f" class="sec sec-last"><h3 id="s2ftitle">Identification of Metabolites</h3><p id="__p28" class="p p-first">On the loading plot, positive signals corresponded to the metabolites that had increased concentrations in the sera from patients in the ALCF group. Conversely, a negative signal corresponded to metabolites that had an increased concentration in the sera of patients in the CLF group.</p><p id="__p29" class="p p-last">The buckets were designated according to their central chemical-shift values. Their most probable assignment to a specific metabolite was given according to the spectral assignment and its detailed appearance (multiplet, high-resolution peaks, and broad signals), as previously described in the literature <a href="#pone.0089230-Nicholson1" rid="pone.0089230-Nicholson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269738" role="button" aria-expanded="false" aria-haspopup="true">[20]</a>, <a href="#pone.0089230-Wevers1" rid="pone.0089230-Wevers1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269747" role="button" aria-expanded="false" aria-haspopup="true">[21]</a>, and according to our previous signal assignments <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269743" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>, <a href="#pone.0089230-Nahon1" rid="pone.0089230-Nahon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269748" role="button" aria-expanded="false" aria-haspopup="true">[22]</a>. To help identify the metabolites, statistical analysis of total-correlation spectroscopy was performed (data not shown) <a href="#pone.0089230-Cloarec1" rid="pone.0089230-Cloarec1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269762" role="button" aria-expanded="false" aria-haspopup="true">[23]</a>.</p></div></div><div id="s3" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Patients’ Characteristics and PCA Analysis</h3><p id="__p30" class="p p-first">A total of 130 patients fulfilled the inclusion criteria: there were 35 patients in the ACLF group and 95 patients in the CLF group. A flow chart of the patients’ characteristics is presented in <a href="/pmc/articles/PMC3929651/figure/pone-0089230-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0089230-g001" rid-ob="ob-pone-0089230-g001" co-legend-rid="lgnd_pone-0089230-g001"><span>Figure 1</span></a>. The data obtained by bucketing the spectra of 130 sera were first analyzed by PCA (not shown). From this analysis, seven outliers were identified: two in the CLF group and five in the ACLF group. The two outliers in the CLF group exhibited high levels of ethanol: 1.11 and 3.66 ppm. Of the five outliers in the ACLF group, three concerned hemorrhagic shock previously transfused. All these outliers were excluded from the OPLS analysis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0089230-g001" co-legend-rid="lgnd_pone-0089230-g001"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g001/" target="figure" rid-figpopup="pone-0089230-g001" rid-ob="ob-pone-0089230-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814065070320" class="figure"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g001/" target="figure" rid-figpopup="pone-0089230-g001" rid-ob="ob-pone-0089230-g001"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3929651_pone.0089230.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0089230.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3929651/bin/pone.0089230.g001.jpg"></a></div><div id="largeobj_idm139814065070320" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3929651/figure/pone-0089230-g001/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0089230-g001"><div><a class="figpopup" href="/pmc/articles/PMC3929651/figure/pone-0089230-g001/" target="figure" rid-figpopup="pone-0089230-g001" rid-ob="ob-pone-0089230-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Flow chart of the patients.</strong></div></div></div><p id="__p31" class="p">Demographic, clinical, and biological features of all patients included in the study are displayed in <a href="/pmc/articles/PMC3929651/table/pone-0089230-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0089230-t001" rid-ob="ob-pone-0089230-t001" co-legend-rid=""><span>Table 1</span></a>, and specific characteristics of the ICU patients included in the OPLS analysis are displayed in <a href="/pmc/articles/PMC3929651/table/pone-0089230-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0089230-t002" rid-ob="ob-pone-0089230-t002" co-legend-rid=""><span>Table 2</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0089230-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Baseline characteristics of the overall population.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814065169984" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Factor</td><td align="left" rowspan="1" colspan="1">CLF group(<em>n</em> = 95)</td><td align="left" rowspan="1" colspan="1">ACLF group(<em>n</em> = 35)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<strong>Age (years)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">58.1±1.0</td><td align="left" rowspan="1" colspan="1">58.9±1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Male gender</strong>
<sup>b</sup>
</td><td align="left" rowspan="1" colspan="1">85 (84%)</td><td align="left" rowspan="1" colspan="1">27 (87%)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>ALT (UI/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">54.6±6.0</td><td align="left" rowspan="1" colspan="1">142.3±69.5<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>AST (UI/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">94.5±14.5</td><td align="left" rowspan="1" colspan="1">532.5±275.5<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Albumin (g/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">37.1±0.7</td><td align="left" rowspan="1" colspan="1">31.4±1.2<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Prothrombin level (% control)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">65.7±2.2</td><td align="left" rowspan="1" colspan="1">34.7±2.8<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Bilirubin (µmol/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">45.3±7.6</td><td align="left" rowspan="1" colspan="1">75.2±14.4</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Child–Pugh score</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">7.0±0.2</td><td align="left" rowspan="1" colspan="1">9.6±0.3<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>MELD score</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">13.4±0.6</td><td align="left" rowspan="1" colspan="1">25.6±1.8<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Creatinine (µmol/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">85.3±3.5</td><td align="left" rowspan="1" colspan="1">158.6±18.8<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Blood glucose (mmol/L)</strong>
</td><td align="left" rowspan="1" colspan="1">6.6±0.2</td><td align="left" rowspan="1" colspan="1">8.3±0.8<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>White blood-cell count (G/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">6.1±0.2</td><td align="left" rowspan="1" colspan="1">12.6±1.6<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Paletted count (G/L)</strong>
<sup>a</sup>
</td><td align="left" rowspan="1" colspan="1">137.7±7.5</td><td align="left" rowspan="1" colspan="1">101.4±12.9<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Hemoglobinemia (g/L)</strong>
</td><td align="left" rowspan="1" colspan="1">12.6±0.2</td><td align="left" rowspan="1" colspan="1">8.6±0.4<sup>*</sup>
</td></tr></tbody></table></div><div id="largeobj_idm139814065169984" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC3929651/table/pone-0089230-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><sup></sup>Note. All biological and clinical parameters were recorded at inclusion.</div><div id="nt102"><sup>a</sup>Mean ± SEM.</div><div id="nt103"><sup>b</sup>Number (percentage) of patients.</div><div id="nt104"><sup></sup>*<em>p</em>&lt;0.05 between ACLF and CLF groups.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0089230-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Characteristics of patients with ACLF included in the OPLS analysis.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814050809744" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Initially diagnosed in the ICU</td><td align="left" rowspan="1" colspan="1">30</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GIB</td><td align="left" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemorrhagic shock</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe sepsis</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Septic shock</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Acute kidney failure</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hepatic encephalopathy</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Previous CPT</strong>
</td><td align="left" rowspan="1" colspan="1">7.6±2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Admission CPT</strong>
</td><td align="left" rowspan="1" colspan="1">9.7±2.0<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Mechanical ventilation (n)</strong>
</td><td align="left" rowspan="1" colspan="1">16/30</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Catecholamines (n)</strong>
</td><td align="left" rowspan="1" colspan="1">7/30</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>SOFA</strong>
</td><td align="left" rowspan="1" colspan="1">7.7±3.6</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Encephalopathy (0/I/II/III/IV)</strong>
</td><td align="left" rowspan="1" colspan="1">3/11/10/1/6</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Lactate (mM)</strong>
</td><td align="left" rowspan="1" colspan="1">5.7±6.3</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>Death (n)</strong>
</td><td align="left" rowspan="1" colspan="1">6/30</td></tr></tbody></table></div><div id="largeobj_idm139814050809744" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC3929651/table/pone-0089230-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt105"><sup></sup>*<em>p</em>&lt;0.01 between previous and admission CPTs.</div><div id="nt106"><sup></sup>Notes: SOFA: Sequential Organ Failure Assessment; CPT: Child–Pugh–Turcott score; GIB: gastrointestinal bleeding.</div></div></div></div><div id="s3b" class="sec"><h3 id="s3btitle">OPLS Model and Their Validation</h3><p id="__p38" class="p p-first">Spectra of the sera from the CLF and ACLF groups were identified using the OPLS model, as shown in the score plot in <a href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002" co-legend-rid="lgnd_pone-0089230-g002"><span>Figure 2A</span></a>. Examples of typical spectra from each group are shown in <a href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002" co-legend-rid="lgnd_pone-0089230-g002"><span>Figure 2B and C</span></a>. The model was built with one predictive and two Y-orthogonal components, and exhibited a good explained variance (<em>R</em>
<sup>2</sup>Y) of 0.73 and a predictability (Q<sup>2</sup>
<em>Y</em>) of 0.63.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0089230-g002" co-legend-rid="lgnd_pone-0089230-g002"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814062548544" class="figure"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3929651_pone.0089230.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0089230.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3929651/bin/pone.0089230.g002.jpg"></a></div><div id="largeobj_idm139814062548544" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0089230-g002"><div><a class="figpopup" href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>OPLS score plot and spectra of the CLF and ACLF patients.</strong><p id="__p39">A: Score plot separating CLF (blue) and ACLF (red) patients. B and C: Representative spectra showing the metabolic differences between patients with CLF or ACLF. Legends: a: -CH<sub>3</sub> of fatty acid; b; -CH<sub>2</sub> of fatty acid; c: glucose (C) and hydroxy-ethyl starch (B); d: fumaric acid; 1: cholesterol; 2: hydroxybutyrate; 3: lactate; 4: acetoacetate; 5: pyruvate; 6: glutamine; 7: creatinine; 8 &amp; 9: aromatic amino acids (phenylalanine and tyrosine).</p></div></div></div><p id="__p40">On the score plot, the spectra from the CLF and ACLF groups were well separated along the horizontal axis. Nevertheless, four patients from the ACLF group were misclassified and had similar metabolomic profiles to patients from the CLF group: two patients with ACLF had been hospitalized in the ICU for gastrointestinal bleeding, which was not related to portal hypertension and was not severe, one had acute kidney injury related to acute cardiac insufficiency, and one had an acute episode of seizure related to alcohol withdrawal. All these patients were alive after hospitalization in the ICU, and none had major impairment of liver function during their stay in the ICU. Two patients from the CLF group were misclassified on the score plot in the ACLF group: one had liver and kidney failure and died at 1 month after inclusion, and the other was initially classified as Child A at admission although the final diagnosis was non-severe acute alcoholic hepatitis.</p><p id="__p41">The model was internally validated, as all <em>Q</em>
<sup>2</sup>Y and <em>R</em>
<sup>2</sup>Y values obtained with the permuted Y were smaller than those from the model. Intercept values for <em>Q</em>
<sup>2</sup>Y and <em>R</em>
<sup>2</sup>Y, obtained from the permutation plot (not shown), were, respectively, −0.22 and 0.19.</p><p id="__p42" class="p p-last">To evaluate that the difference of the group size did not influence our results, we have built 500 different models. Those OPLS models were built with 30 patients of CLF group randomly selected and 30 ACLF cases. The distribution of Q2Y values obtained described the results. The median of this Q2Y distribution was 0.64 and the smaller Q2Y value was 0.49. For each NMR variable, distribution of the regression coefficient was also estimated. The variables considered as significant in the original model were also significant in the 500 resampled models.</p></div><div id="s3c" class="sec sec-last"><h3 id="s3ctitle">Discriminants Metabolites</h3><p id="__p43" class="p p-first">The metabolites that differed between the groups could be identified within the sera spectra according to their loading plots (<a href="/pmc/articles/PMC3929651/figure/pone-0089230-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0089230-g003" rid-ob="ob-pone-0089230-g003" co-legend-rid="lgnd_pone-0089230-g003"><span>Figure 3</span></a>). <a href="/pmc/articles/PMC3929651/table/pone-0089230-t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0089230-t003" rid-ob="ob-pone-0089230-t003" co-legend-rid=""><span>Table 3</span></a> presents the nine metabolites that were significantly correlated with the model and their variations according to group.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0089230-g003" co-legend-rid="lgnd_pone-0089230-g003"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g003/" target="figure" rid-figpopup="pone-0089230-g003" rid-ob="ob-pone-0089230-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814059776640" class="figure"><a href="/pmc/articles/PMC3929651/figure/pone-0089230-g003/" target="figure" rid-figpopup="pone-0089230-g003" rid-ob="ob-pone-0089230-g003"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3929651_pone.0089230.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0089230.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3929651/bin/pone.0089230.g003.jpg"></a></div><div id="largeobj_idm139814059776640" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3929651/figure/pone-0089230-g003/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone-0089230-g003"><div><a class="figpopup" href="/pmc/articles/PMC3929651/figure/pone-0089230-g003/" target="figure" rid-figpopup="pone-0089230-g003" rid-ob="ob-pone-0089230-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>OPLS line plot showing the discriminant metabolites between patients with CLF or ACLF.</strong><p id="__p44">Variations of metabolites are represented using a line plot between 0–9 ppm. Positive signals correspond to metabolites present at increased concentrations in the ACLF group. Conversely, negative signals correspond to metabolites present at increased concentrations in CLF group. The buckets are labeled according to metabolite assignment, as presented in <a href="/pmc/articles/PMC3929651/table/pone-0089230-t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0089230-t003" rid-ob="ob-pone-0089230-t003" co-legend-rid=""><span>Table 3</span></a>.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0089230-t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Discriminant metabolites observed by <sup>1</sup>H-NMR spectroscopy.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139814062365712" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">No. of metabolite</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Chemical shift (ppm) and multiplicity<sup>$</sup>
</td><td align="left" rowspan="1" colspan="1">
<em>r</em>
<sup>#</sup>
</td><td align="left" rowspan="1" colspan="1">
<em>p</em>
<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">Group</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<strong>1</strong>
</td><td align="left" rowspan="1" colspan="1">Lipids (mainly HDL)</td><td align="left" rowspan="1" colspan="1">0.8<sup>b</sup>; 1.2<sup>b</sup>
</td><td align="left" rowspan="1" colspan="1">−0.46</td><td align="left" rowspan="1" colspan="1">4,8×10<sup>−8</sup>
</td><td align="left" rowspan="1" colspan="1">CLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>2</strong>
</td><td align="left" rowspan="1" colspan="1">Hydroxybutyrate</td><td align="left" rowspan="1" colspan="1">1.13<sup>d</sup>
</td><td align="left" rowspan="1" colspan="1">+0.38</td><td align="left" rowspan="1" colspan="1">1.7×10<sup>−6</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>3</strong>
</td><td align="left" rowspan="1" colspan="1">Lactate</td><td align="left" rowspan="1" colspan="1">1.30<sup>d</sup>; 4.13<sup>q</sup>
</td><td align="left" rowspan="1" colspan="1">+0.55</td><td align="left" rowspan="1" colspan="1">2.6×10<sup>−11</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>4</strong>
</td><td align="left" rowspan="1" colspan="1">Acetoacetate</td><td align="left" rowspan="1" colspan="1">2.11<sup>s</sup>
</td><td align="left" rowspan="1" colspan="1">+0.43</td><td align="left" rowspan="1" colspan="1">3.1×10<sup>−7</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>5</strong>
</td><td align="left" rowspan="1" colspan="1">Pyruvate</td><td align="left" rowspan="1" colspan="1">2.36<sup>s</sup>
</td><td align="left" rowspan="1" colspan="1">+0.54</td><td align="left" rowspan="1" colspan="1">4.9×10<sup>−11</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>6</strong>
</td><td align="left" rowspan="1" colspan="1">Glutamine, glutamate</td><td align="left" rowspan="1" colspan="1">2.42<sup>m</sup>
</td><td align="left" rowspan="1" colspan="1">+0.48</td><td align="left" rowspan="1" colspan="1">9.6×10<sup>−9</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>7</strong>
</td><td align="left" rowspan="1" colspan="1">Creatinine</td><td align="left" rowspan="1" colspan="1">3.03<sup>s</sup> 4.04<sup>s</sup>
</td><td align="left" rowspan="1" colspan="1">+0.56</td><td align="left" rowspan="1" colspan="1">1.1×10<sup>−12</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>8</strong>
</td><td align="left" rowspan="1" colspan="1">Tyrosine</td><td align="left" rowspan="1" colspan="1">6.88<sup>m</sup>;7.18<sup>d</sup>
</td><td align="left" rowspan="1" colspan="1">+0.45</td><td align="left" rowspan="1" colspan="1">9.0×10<sup>−8</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr><tr><td align="left" rowspan="1" colspan="1">
<strong>9</strong>
</td><td align="left" rowspan="1" colspan="1">Phenylalanine</td><td align="left" rowspan="1" colspan="1">7.31<sup>m</sup>; 7.40<sup>m</sup>
</td><td align="left" rowspan="1" colspan="1">+0.63</td><td align="left" rowspan="1" colspan="1">3.3×10<sup>−15</sup>
</td><td align="left" rowspan="1" colspan="1">ACLF</td></tr></tbody></table></div><div id="largeobj_idm139814062365712" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC3929651/table/pone-0089230-t003/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt107"><sup></sup>The principal discriminant metabolites are ordered according to the loading plots of patients with CLF and ACLF. The number of the metabolite corresponds to the number in the line plot in <a href="/pmc/articles/PMC3929651/figure/pone-0089230-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0089230-g002" rid-ob="ob-pone-0089230-g002" co-legend-rid="lgnd_pone-0089230-g002"><span>Figure 2</span></a>. The chemical shift and multiplicity correspond to those found in the <sup>1</sup>H-NMR spectra of the patients’ sera.</div><div id="nt108"><sup>$</sup>ppm: parts per million. s, singlet; b, broad; d, doublet; dd, doublet of doublet; t, triplet, m multiplet; q, quadriplet.</div><div id="nt109"><sup>#</sup>A positive correlation (<em>r</em>) indicates an increased concentration in the ACLF group and a negative correlation indicates a decreased concentration in the CLF group.</div><div id="nt110"><sup></sup>*A <em>p</em>-value &lt;2.4×10<sup>−6</sup> is significant.</div></div></div><p id="__p49">In the <sup>1</sup>H-NMR spectra of sera, the lipids were detected as broad resonances of fatty-acid methyl and methylene moieties at 0.8 and 1.24 ppm, respectively, and the N-trimethyl moiety of choline was included in phospholipids at 3.2 ppm. The line shape of the methyl and methylene fatty-acid resonances, at 0.8 and 1.24 ppm, depended on the size of the lipoprotein particles. It has been widely reported that high-density lipid (HDL) particles produce resonances with lower chemical shifts than low-density lipoprotein (LDL and VLDL) particles. Interestingly, lipoproteins with higher densities were significantly elevated in the CLF group. For VLDL, corresponding to the highest chemical shifts in methyl and methylene resonances, no differences were found.</p><p id="__p50">Lactate was an important metabolite that discriminated between the ACLF and CLF groups. Patients with ACLF had significantly higher lactate signals than patients in the CLF group. Pyruvate and ketone bodies (mainly acetoacetate) were significantly higher in the ACLF group than in CLF group.</p><p id="__p51" class="p p-last">Several amino acids could be identified in the spectra. Glutamine and glutamate were significantly higher in the ACLF group than in the CLF group. Aromatic amino acids, such tyrosine and phenylalanine, were significantly higher in the ACLF group compared to the CLF group. Creatinine was also higher in the spectra of patients in the ACLF group compared to the CLF group.</p></div></div><div id="s4" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s4title">Discussion</h2><p id="__p52" class="p p-first">This preliminary study was conducted in a cohort of cirrhotic patients hospitalized in ICU for acute event and cirrhotic outpatients with compensated or decompensated but stable liver function. This investigation clearly shows a difference in the metabolomic profiles of the two studied populations. The comparison of these two populations of cirrhotic patients was preferred than comparison of ACLF cirrhotic patient and healthy volunteers. In the last case, metabolomics difference should be only due to chronic liver failure and not to acute impairment of the liver function.</p><p id="__p53">During the evolution of chronic liver failure, several changes in liver metabolism were detected. In our previous study, stable patients with alcoholic cirrhosis and various degrees of liver injury (evaluated by the MELD score) were included. In severe chronic liver failure, metabolism of lipids, glucose, and ketone bodies were significantly discriminants <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269750" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>. Interestingly, in the present study, the metabolomic profile of ACLF patients was not the same metabolomic profile than determine in CLF group and in our previous study (6). In the ACLF group, lipid metabolism, lactate, amino-acid metabolism, and urea metabolism were affected by impaired liver function. This point is important as it differentiated the metabolomic fingerprints of chronic liver failure in acute-on-chronic liver failure.</p><p id="__p54">In the CLF group, HDL signal were higher than in the ACLF group, but there was no difference with regards to VLDL and LDL. This is probably because ACLF patients were not fasted whereas those in the CLF group were. Thus, this may have caused the lipid signals to be higher in ACLF sera. Despite this discrepancy, the resonances corresponding to lipids were not increased in ACLF patients. Moreover, the HDL-lipid region was lower in ACLF sera compared to that of fasting patients in the CLF group. In several studies, higher HDL levels seem to reflect good hepatic function. The liver plays a key role in lipid metabolism, and low HDL levels seem to be caused by the severity of the chronic liver disease rather than indicating an acute episode of chronic impairment. A rise of serum-lactate concentration is common in cases of acute liver failure and has been proposed as a prognostic marker <a href="#pone.0089230-Bernal1" rid="pone.0089230-Bernal1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269736" role="button" aria-expanded="false" aria-haspopup="true">[24]</a>. The production of lactate is also impaired in chronic liver failure accompanied by a decrease in hepatic pyruvate dehydrogenase activity <a href="#pone.0089230-Shangraw1" rid="pone.0089230-Shangraw1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269751" role="button" aria-expanded="false" aria-haspopup="true">[25]</a>. Moreover, lactate is a major biomarker for tissue hypoxia and necrosis. Hepatic necrosis and inflammation, detected by histological examination of a liver biopsy, correlate well with the severity of ACLF and a poor outcome <a href="#pone.0089230-Rastogi1" rid="pone.0089230-Rastogi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269769" role="button" aria-expanded="false" aria-haspopup="true">[26]</a>. In our previous study, lactate was a key-indicator metabolite in patients with cirrhosis and the highest Model for End-Stage Liver-Disease scores. In patients with ACLF, increased lactate concentration may be related to the superimposed impairment of hepatic lactate catabolism and increased production of lactate caused by hypoxia and liver necrosis. Ketone bodies (including hydroxybutyrate and acetoacetate) were also increased in ACLF sera. These metabolites mainly originate from the metabolism of fatty acids via the beta-oxidation pathway, which produces acetyl moieties that enter the TCA cycle. Taken together, a decrease in HDL and an increase in lactate and ketone bodies have led to the hypothesis that aerobic glycolysis is modulated towards anaerobic and lipid metabolisms.</p><p id="__p55">The perturbation of the aromatic acids metabolism (phenylalanine and tyrosine metabolism), has been found in different etiologies of liver injury, such as traumatic injury, and seems to be early markers <a href="#pone.0089230-Ranjan1" rid="pone.0089230-Ranjan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269737" role="button" aria-expanded="false" aria-haspopup="true">[27]</a>. In patients with chronic liver disease and who have had an acute event, such as gastrointestinal bleeding, infection, acute alcoholic hepatitis, or encephalopathy, the aromatic acids are increased in relation to inflammation and hepatic necrosis <a href="#pone.0089230-Rosen1" rid="pone.0089230-Rosen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269754" role="button" aria-expanded="false" aria-haspopup="true">[28]</a>. Systemic inflammation occurs in patients with cirrhosis who have a superimposed liver insult, and is significantly related to bleeding, sepsis, and long-term outcomes <a href="#pone.0089230-Cazzaniga1" rid="pone.0089230-Cazzaniga1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269739" role="button" aria-expanded="false" aria-haspopup="true">[29]</a>. Inflammation plays a key role in worsening the patient’s health, and elevated levels of multiple pro-inflammatory cytokines have been described in ACLF <a href="#pone.0089230-Sen1" rid="pone.0089230-Sen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269770" role="button" aria-expanded="false" aria-haspopup="true">[30]</a>.</p><p id="__p56">The liver is the major organ for urea metabolism. Impaired urea metabolism leads to decreased ammonia detoxification and is responsible for the increase levels of glutamine and glutamate. This increase occurs in different situations in patients with chronic liver diseases: gastrointestinal bleeding, infection <a href="#pone.0089230-Rosen1" rid="pone.0089230-Rosen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269765" role="button" aria-expanded="false" aria-haspopup="true">[28]</a>, hepatic encephalopathy, or end-stage liver disease <a href="#pone.0089230-Amathieu1" rid="pone.0089230-Amathieu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269756" role="button" aria-expanded="false" aria-haspopup="true">[6]</a>.</p><p id="__p57">Then, our metabolomic approach identifies several indicative factors within one experiment, whereas these factors have been only previously described in a range of situations in patients with cirrhosis. The fact that lactate and creatinine, for example, represents established biomarkers in the management of decompensated cirrhosis is not novel at all. The improvement reach by the metabolomics approach could be the simultaneous evaluation of the metabolites of interest in a profile directly correlated to the clinical status.</p><p id="__p58">Two patients within our CLF group were misclassified in the score plot and had similar metabolomic profile than patients of ACLF group. Both patients had impaired liver function: this was caused by acute alcoholic hepatitis for one, and cardiac failure for the other. Metabolomic fingerprints seemed able to reflect changes in liver function before standard biological laboratory tests could. In addition, four patients from the ACLF group were misclassified as being in the CLF group. They had minor gastrointestinal bleeding, acute kidney injury, encephalopathy that was not related to liver disease, and none or minor liver injury. Metabolomic profiles could excluded acute liver damage better than standard biological laboratory test.</p><p id="__p59">The main limitation encountered in a translational metabolomic approach to liver disease is methodological bias when selecting patients, which limits the confidence that can be drawn from conclusions. We attempted to avoid these pitfalls by constructing well-defined subgroups of patients according to their stage of underlying liver disease, with a control group composed of compensated or uncompensated (CLF group), but stable, cirrhosis, and a group of patients with cirrhosis who had an acute event that was responsible for the superimposed liver impairment (ACLF group). We also focused specifically on the etiology of alcoholism to avoid any potential specific influence of viral or non-alcoholic-related liver disease on the metabolomic profiles of the sera, as has been previously reported <a href="#pone.0089230-Qi1" rid="pone.0089230-Qi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_688269755" role="button" aria-expanded="false" aria-haspopup="true">[10]</a>.</p><p id="__p60">In this setting, the present data enabled us to form several hypotheses and conclusions. First, the metabolomic fingerprints reflect major changes to liver function, such as energy metabolism, amino-acid metabolism, and urea metabolism. Secondly, in cases of acute impairment, the changes correlated with the severity of liver failure (as shown in our previous study) and they were increased. Other modulations were not found in chronic liver failure and increase in case of acute dysfunction of the liver such as the aromatic acids. Third, increase creatinine in the ACLF group reflects extra-liver failure with renal injury comparatively of cirrhotic patients of the CLF group. Fourth, the metabolomic changes were related to inflammation and necrosis. Systemic inflammation and necrosis are known to play a major role in the pathophysiology of acute-on-chronic liver failure and the failure of other organs. In addition, our metabolomic profiles improved the classification of patients with or without acute-on-chronic liver failure, as was shown with the initially misclassified patients.</p><p id="__p61" class="p p-last">A metabolomic approach assesses the liver markers and other organ impairments in serum samples using a unique experiment: this profiling provides complete and multivariate information on the metabolomic changes related to ACLF and can stratify the cases. The use of this technique as a diagnostic and prognostic tool for patients with ACLF needs to be further investigated. Finally, further confirmation of our metabolomic findings needs to be tested in larger prospective cohorts of ICU patients being followed up for cirrhosis in order to better define clear association between metabolomic profiles and diagnosis or prognosis. Such an approach will improve our understanding of the involvement of the biological pathways in ACLF.</p></div><div id="idm139814067450256" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139814067450256title">Funding Statement</h2><p>The authors have no support or funding to report.</p></div><div id="idm139814060674528" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139814060674528title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0089230-Olson1">1. <span class="mixed-citation">
Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, et al. (2011) <span class="ref-title">Intensive care of the patient with cirrhosis</span>. <span class="ref-journal">Hepatology</span>
<span class="ref-vol">54</span>: 1864–1872. [<a href="/pubmed/21898477" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Intensive+care+of+the+patient+with+cirrhosis&amp;author=JC+Olson&amp;author=JA+Wendon&amp;author=DJ+Kramer&amp;author=V+Arroyo&amp;author=R+Jalan&amp;volume=54&amp;publication_year=2011&amp;pages=1864-1872&amp;pmid=21898477&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Jalan1">2. <span class="mixed-citation">
Jalan R, Williams R (2002) <span class="ref-title">Acute-on-chronic liver failure: pathophysiological basis of therapeutic options</span>. <span class="ref-journal">Blood purification</span>
<span class="ref-vol">20</span>: 252–261. [<a href="/pubmed/11867872" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood+purification&amp;title=Acute-on-chronic+liver+failure:+pathophysiological+basis+of+therapeutic+options&amp;author=R+Jalan&amp;author=R+Williams&amp;volume=20&amp;publication_year=2002&amp;pages=252-261&amp;pmid=11867872&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Moreau1">3. <span class="mixed-citation">Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, et al... (2013) Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144: 1426–1437, 1437 e1421–1429. [<a href="/pubmed/23474284" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Sarin1">4. <span class="mixed-citation">
Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. (2009) <span class="ref-title">Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)</span>. <span class="ref-journal">Hepatology international</span>
<span class="ref-vol">3</span>: 269–282. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2712314/">PMC free article</a>]</span> [<a href="/pubmed/19669378" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology+international&amp;title=Acute-on-chronic+liver+failure:+consensus+recommendations+of+the+Asian+Pacific+Association+for+the+study+of+the+liver+(APASL)&amp;author=SK+Sarin&amp;author=A+Kumar&amp;author=JA+Almeida&amp;author=YK+Chawla&amp;author=ST+Fan&amp;volume=3&amp;publication_year=2009&amp;pages=269-282&amp;pmid=19669378&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Dunn1">5. <span class="mixed-citation">
Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) <span class="ref-title">Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy</span>. <span class="ref-journal">Chemical Society reviews</span>
<span class="ref-vol">40</span>: 387–426. [<a href="/pubmed/20717559" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chemical+Society+reviews&amp;title=Systems+level+studies+of+mammalian+metabolomes:+the+roles+of+mass+spectrometry+and+nuclear+magnetic+resonance+spectroscopy&amp;author=WB+Dunn&amp;author=DI+Broadhurst&amp;author=HJ+Atherton&amp;author=R+Goodacre&amp;author=JL+Griffin&amp;volume=40&amp;publication_year=2011&amp;pages=387-426&amp;pmid=20717559&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Amathieu1">6. <span class="mixed-citation">
Amathieu R, Nahon P, Triba M, Bouchemal N, Trinchet JC, et al. (2011) <span class="ref-title">Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis</span>. <span class="ref-journal">Journal of proteome research</span>
<span class="ref-vol">10</span>: 3239–3245. [<a href="/pubmed/21568267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+proteome+research&amp;title=Metabolomic+approach+by+1H+NMR+spectroscopy+of+serum+for+the+assessment+of+chronic+liver+failure+in+patients+with+cirrhosis&amp;author=R+Amathieu&amp;author=P+Nahon&amp;author=M+Triba&amp;author=N+Bouchemal&amp;author=JC+Trinchet&amp;volume=10&amp;publication_year=2011&amp;pages=3239-3245&amp;pmid=21568267&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-MartinezGranados1">7. <span class="mixed-citation">
Martinez-Granados B, Morales JM, Rodrigo JM, Del Olmo J, Serra MA, et al. (2011) <span class="ref-title">Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies</span>. <span class="ref-journal">International journal of molecular medicine</span>
<span class="ref-vol">27</span>: 111–117. [<a href="/pubmed/21072494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+journal+of+molecular+medicine&amp;title=Metabolic+profile+of+chronic+liver+disease+by+NMR+spectroscopy+of+human+biopsies&amp;author=B+Martinez-Granados&amp;author=JM+Morales&amp;author=JM+Rodrigo&amp;author=J+Del+Olmo&amp;author=MA+Serra&amp;volume=27&amp;publication_year=2011&amp;pages=111-117&amp;pmid=21072494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Yu1">8. <span class="mixed-citation">
Yu K, Sheng G, Sheng J, Chen Y, Xu W, et al. (2007) <span class="ref-title">A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus</span>. <span class="ref-journal">Journal of proteome research</span>
<span class="ref-vol">6</span>: 2413–2419. [<a href="/pubmed/17539670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+proteome+research&amp;title=A+metabonomic+investigation+on+the+biochemical+perturbation+in+liver+failure+patients+caused+by+hepatitis+B+virus&amp;author=K+Yu&amp;author=G+Sheng&amp;author=J+Sheng&amp;author=Y+Chen&amp;author=W+Xu&amp;volume=6&amp;publication_year=2007&amp;pages=2413-2419&amp;pmid=17539670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Jimenez1">9. <span class="mixed-citation">
Jimenez B, Montoliu C, MacIntyre DA, Serra MA, Wassel A, et al. (2010) <span class="ref-title">Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance</span>. <span class="ref-journal">Journal of proteome research</span>
<span class="ref-vol">9</span>: 5180–5187. [<a href="/pubmed/20690770" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+proteome+research&amp;title=Serum+metabolic+signature+of+minimal+hepatic+encephalopathy+by+(1)H-nuclear+magnetic+resonance&amp;author=B+Jimenez&amp;author=C+Montoliu&amp;author=DA+MacIntyre&amp;author=MA+Serra&amp;author=A+Wassel&amp;volume=9&amp;publication_year=2010&amp;pages=5180-5187&amp;pmid=20690770&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Qi1">10. <span class="mixed-citation">
Qi S, Tu Z, Ouyang X, Wang L, Peng W, et al. (2012) <span class="ref-title">Comparison of the metabolic profiling of hepatitis B virus-infected cirrhosis and alcoholic cirrhosis patients by using (1) H NMR-based metabonomics</span>. <span class="ref-journal">Hepatology research : the official journal of the Japan Society of Hepatology</span>
<span class="ref-vol">42</span>: 677–685. [<a href="/pubmed/22404306" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology+research+:+the+official+journal+of+the+Japan+Society+of+Hepatology&amp;title=Comparison+of+the+metabolic+profiling+of+hepatitis+B+virus-infected+cirrhosis+and+alcoholic+cirrhosis+patients+by+using+(1)+H+NMR-based+metabonomics&amp;author=S+Qi&amp;author=Z+Tu&amp;author=X+Ouyang&amp;author=L+Wang&amp;author=W+Peng&amp;volume=42&amp;publication_year=2012&amp;pages=677-685&amp;pmid=22404306&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Qi2">11. <span class="mixed-citation">
Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, et al. (2012) <span class="ref-title">(1)H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis</span>. <span class="ref-journal">World journal of gastroenterology : WJG</span>
<span class="ref-vol">18</span>: 285–290. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3261547/">PMC free article</a>]</span> [<a href="/pubmed/22294833" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+journal+of+gastroenterology+:+WJG&amp;title=(1)H+NMR-based+serum+metabolic+profiling+in+compensated+and+decompensated+cirrhosis&amp;author=SW+Qi&amp;author=ZG+Tu&amp;author=WJ+Peng&amp;author=LX+Wang&amp;author=X+Ou-Yang&amp;volume=18&amp;publication_year=2012&amp;pages=285-290&amp;pmid=22294833&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Tripathi1">12. <span class="mixed-citation">
Tripathi P, Bala L, Saxena R, Yachha SK, Roy R, et al. (2009) <span class="ref-title">1H NMR spectroscopic study of blood serum for the assessment of liver function in liver transplant patients</span>. <span class="ref-journal">Journal of gastrointestinal and liver diseases : JGLD</span>
<span class="ref-vol">18</span>: 329–336. [<a href="/pubmed/19795028" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+gastrointestinal+and+liver+diseases+:+JGLD&amp;title=1H+NMR+spectroscopic+study+of+blood+serum+for+the+assessment+of+liver+function+in+liver+transplant+patients&amp;author=P+Tripathi&amp;author=L+Bala&amp;author=R+Saxena&amp;author=SK+Yachha&amp;author=R+Roy&amp;volume=18&amp;publication_year=2009&amp;pages=329-336&amp;pmid=19795028&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Serkova1">13. <span class="mixed-citation">
Serkova NJ, Zhang Y, Coatney JL, Hunter L, Wachs ME, et al. (2007) <span class="ref-title">Early detection of graft failure using the blood metabolic profile of a liver recipient</span>. <span class="ref-journal">Transplantation</span>
<span class="ref-vol">83</span>: 517–521. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2709529/">PMC free article</a>]</span> [<a href="/pubmed/17318087" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Early+detection+of+graft+failure+using+the+blood+metabolic+profile+of+a+liver+recipient&amp;author=NJ+Serkova&amp;author=Y+Zhang&amp;author=JL+Coatney&amp;author=L+Hunter&amp;author=ME+Wachs&amp;volume=83&amp;publication_year=2007&amp;pages=517-521&amp;pmid=17318087&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Saxena1">14. <span class="mixed-citation">
Saxena V, Gupta A, Nagana Gowda GA, Saxena R, Yachha SK, et al. (2006) <span class="ref-title">1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure</span>. <span class="ref-journal">NMR in biomedicine</span>
<span class="ref-vol">19</span>: 521–526. [<a href="/pubmed/16598697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=NMR+in+biomedicine&amp;title=1H+NMR+spectroscopy+for+the+prediction+of+therapeutic+outcome+in+patients+with+fulminant+hepatic+failure&amp;author=V+Saxena&amp;author=A+Gupta&amp;author=GA+Nagana+Gowda&amp;author=R+Saxena&amp;author=SK+Yachha&amp;volume=19&amp;publication_year=2006&amp;pages=521-526&amp;pmid=16598697&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Dellinger1">15. <span class="mixed-citation">
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) <span class="ref-title">Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008</span>. <span class="ref-journal">Critical care medicine</span>
<span class="ref-vol">36</span>: 296–327. [<a href="/pubmed/18158437" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Critical+care+medicine&amp;title=Surviving+Sepsis+Campaign:+international+guidelines+for+management+of+severe+sepsis+and+septic+shock:+2008&amp;author=RP+Dellinger&amp;author=MM+Levy&amp;author=JM+Carlet&amp;author=J+Bion&amp;author=MM+Parker&amp;volume=36&amp;publication_year=2008&amp;pages=296-327&amp;pmid=18158437&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Vincent1">16. <span class="mixed-citation">
Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, et al. (1998) <span class="ref-title">Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine</span>. <span class="ref-journal">Critical care medicine</span>
<span class="ref-vol">26</span>: 1793–1800. [<a href="/pubmed/9824069" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Critical+care+medicine&amp;title=Use+of+the+SOFA+score+to+assess+the+incidence+of+organ+dysfunction/failure+in+intensive+care+units:+results+of+a+multicenter,+prospective+study.+Working+group+on+“sepsis-related+problems”+of+the+European+Society+of+Intensive+Care+Medicine&amp;author=JL+Vincent&amp;author=A+de+Mendonca&amp;author=F+Cantraine&amp;author=R+Moreno&amp;author=J+Takala&amp;volume=26&amp;publication_year=1998&amp;pages=1793-1800&amp;pmid=9824069&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Pugh1">17. <span class="mixed-citation">
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) <span class="ref-title">Transection of the oesophagus for bleeding oesophageal varices</span>. <span class="ref-journal">The British journal of surgery</span>
<span class="ref-vol">60</span>: 646–649. [<a href="/pubmed/4541913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+British+journal+of+surgery&amp;title=Transection+of+the+oesophagus+for+bleeding+oesophageal+varices&amp;author=RN+Pugh&amp;author=IM+Murray-Lyon&amp;author=JL+Dawson&amp;author=MC+Pietroni&amp;author=R+Williams&amp;volume=60&amp;publication_year=1973&amp;pages=646-649&amp;pmid=4541913&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Kamath1">18. <span class="mixed-citation">
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. (2001) <span class="ref-title">A model to predict survival in patients with end-stage liver disease</span>. <span class="ref-journal">Hepatology</span>
<span class="ref-vol">33</span>: 464–470. [<a href="/pubmed/11172350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=A+model+to+predict+survival+in+patients+with+end-stage+liver+disease&amp;author=PS+Kamath&amp;author=RH+Wiesner&amp;author=M+Malinchoc&amp;author=W+Kremers&amp;author=TM+Therneau&amp;volume=33&amp;publication_year=2001&amp;pages=464-470&amp;pmid=11172350&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Trygg1">19. <span class="mixed-citation">
Trygg J, Wold S (2002) <span class="ref-title">Othogonal projections to latent structure (OPLS)</span>. <span class="ref-journal">J Chemometrics</span>
<span class="ref-vol">16</span>: 116–128. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Chemometrics&amp;title=Othogonal+projections+to+latent+structure+(OPLS)&amp;author=J+Trygg&amp;author=S+Wold&amp;volume=16&amp;publication_year=2002&amp;pages=116-128&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Nicholson1">20. <span class="mixed-citation">
Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) <span class="ref-title">750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma</span>. <span class="ref-journal">Anal Chem</span>
<span class="ref-vol">67</span>: 793–811. [<a href="/pubmed/7762816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=750+MHz+1H+and+1H-13C+NMR+spectroscopy+of+human+blood+plasma&amp;author=JK+Nicholson&amp;author=PJ+Foxall&amp;author=M+Spraul&amp;author=RD+Farrant&amp;author=JC+Lindon&amp;volume=67&amp;publication_year=1995&amp;pages=793-811&amp;pmid=7762816&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Wevers1">21. <span class="mixed-citation">
Wevers RA, Engelke U, Heerschap A (1994) <span class="ref-title">High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies</span>. <span class="ref-journal">Clin Chem</span>
<span class="ref-vol">40</span>: 1245–1250. [<a href="/pubmed/8013094" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=High-resolution+1H-NMR+spectroscopy+of+blood+plasma+for+metabolic+studies&amp;author=RA+Wevers&amp;author=U+Engelke&amp;author=A+Heerschap&amp;volume=40&amp;publication_year=1994&amp;pages=1245-1250&amp;pmid=8013094&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Nahon1">22. <span class="mixed-citation">
Nahon P, Amathieu R, Triba MN, Bouchemal N, Nault JC, et al. (2012) <span class="ref-title">Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis</span>. <span class="ref-journal">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
<span class="ref-vol">18</span>: 6714–6722. [<a href="/pubmed/23136190" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clinical+cancer+research+:+an+official+journal+of+the+American+Association+for+Cancer+Research&amp;title=Identification+of+serum+proton+NMR+metabolomic+fingerprints+associated+with+hepatocellular+carcinoma+in+patients+with+alcoholic+cirrhosis&amp;author=P+Nahon&amp;author=R+Amathieu&amp;author=MN+Triba&amp;author=N+Bouchemal&amp;author=JC+Nault&amp;volume=18&amp;publication_year=2012&amp;pages=6714-6722&amp;pmid=23136190&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Cloarec1">23. <span class="mixed-citation">
Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, et al. (2005) <span class="ref-title">Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets</span>. <span class="ref-journal">Anal Chem</span>
<span class="ref-vol">77</span>: 1282–1289. [<a href="/pubmed/15732908" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=Statistical+total+correlation+spectroscopy:+an+exploratory+approach+for+latent+biomarker+identification+from+metabolic+1H+NMR+data+sets&amp;author=O+Cloarec&amp;author=ME+Dumas&amp;author=A+Craig&amp;author=RH+Barton&amp;author=J+Trygg&amp;volume=77&amp;publication_year=2005&amp;pages=1282-1289&amp;pmid=15732908&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Bernal1">24. <span class="mixed-citation">
Bernal W, Donaldson N, Wyncoll D, Wendon J (2002) <span class="ref-title">Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study</span>. <span class="ref-journal">Lancet</span>
<span class="ref-vol">359</span>: 558–563. [<a href="/pubmed/11867109" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Blood+lactate+as+an+early+predictor+of+outcome+in+paracetamol-induced+acute+liver+failure:+a+cohort+study&amp;author=W+Bernal&amp;author=N+Donaldson&amp;author=D+Wyncoll&amp;author=J+Wendon&amp;volume=359&amp;publication_year=2002&amp;pages=558-563&amp;pmid=11867109&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Shangraw1">25. <span class="mixed-citation">
Shangraw RE, Rabkin JM, Lopaschuk GD (1998) <span class="ref-title">Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis, transplantation, and dichloroacetate</span>. <span class="ref-journal">The American journal of physiology</span>
<span class="ref-vol">274</span>: G569–577. [<a href="/pubmed/9530159" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+American+journal+of+physiology&amp;title=Hepatic+pyruvate+dehydrogenase+activity+in+humans:+effect+of+cirrhosis,+transplantation,+and+dichloroacetate&amp;author=RE+Shangraw&amp;author=JM+Rabkin&amp;author=GD+Lopaschuk&amp;volume=274&amp;publication_year=1998&amp;pages=G569-577&amp;pmid=9530159&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Rastogi1">26. <span class="mixed-citation">
Rastogi A, Kumar A, Sakhuja P, Bihari C, Gondal R, et al. (2011) <span class="ref-title">Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF)</span>. <span class="ref-journal">Virchows Archiv : an international journal of pathology</span>
<span class="ref-vol">459</span>: 121–127. [<a href="/pubmed/21744153" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virchows+Archiv+:+an+international+journal+of+pathology&amp;title=Liver+histology+as+predictor+of+outcome+in+patients+with+acute-on-chronic+liver+failure+(ACLF)&amp;author=A+Rastogi&amp;author=A+Kumar&amp;author=P+Sakhuja&amp;author=C+Bihari&amp;author=R+Gondal&amp;volume=459&amp;publication_year=2011&amp;pages=121-127&amp;pmid=21744153&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Ranjan1">27. <span class="mixed-citation">
Ranjan P, Gupta A, Kumar S, Gowda GA, Ranjan A, et al. (2006) <span class="ref-title">Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy</span>. <span class="ref-journal">Liver international : official journal of the International Association for the Study of the Liver</span>
<span class="ref-vol">26</span>: 703–707. [<a href="/pubmed/16842327" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Liver+international+:+official+journal+of+the+International+Association+for+the+Study+of+the+Liver&amp;title=Detection+of+new+amino+acid+markers+of+liver+trauma+by+proton+nuclear+magnetic+resonance+spectroscopy&amp;author=P+Ranjan&amp;author=A+Gupta&amp;author=S+Kumar&amp;author=GA+Gowda&amp;author=A+Ranjan&amp;volume=26&amp;publication_year=2006&amp;pages=703-707&amp;pmid=16842327&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Rosen1">28. <span class="mixed-citation">
Rosen HM, Yoshimura N, Hodgman JM, Fischer JE (1977) <span class="ref-title">Plasma amino acid patterns in hepatic encephalopathy of differing etiology</span>. <span class="ref-journal">Gastroenterology</span>
<span class="ref-vol">72</span>: 483–487. [<a href="/pubmed/832796" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Plasma+amino+acid+patterns+in+hepatic+encephalopathy+of+differing+etiology&amp;author=HM+Rosen&amp;author=N+Yoshimura&amp;author=JM+Hodgman&amp;author=JE+Fischer&amp;volume=72&amp;publication_year=1977&amp;pages=483-487&amp;pmid=832796&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Cazzaniga1">29. <span class="mixed-citation">
Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, et al. (2009) <span class="ref-title">The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome</span>. <span class="ref-journal">Journal of hepatology</span>
<span class="ref-vol">51</span>: 475–482. [<a href="/pubmed/19560225" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+hepatology&amp;title=The+systemic+inflammatory+response+syndrome+in+cirrhotic+patients:+relationship+with+their+in-hospital+outcome&amp;author=M+Cazzaniga&amp;author=E+Dionigi&amp;author=G+Gobbo&amp;author=A+Fioretti&amp;author=V+Monti&amp;volume=51&amp;publication_year=2009&amp;pages=475-482&amp;pmid=19560225&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0089230-Sen1">30. <span class="mixed-citation">
Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, et al. (2004) <span class="ref-title">Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study</span>. <span class="ref-journal">Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</span>
<span class="ref-vol">10</span>: 1109–1119. [<a href="/pubmed/15350001" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Liver+transplantation+:+official+publication+of+the+American+Association+for+the+Study+of+Liver+Diseases+and+the+International+Liver+Transplantation+Society&amp;title=Pathophysiological+effects+of+albumin+dialysis+in+acute-on-chronic+liver+failure:+a+randomized+controlled+study&amp;author=S+Sen&amp;author=NA+Davies&amp;author=RP+Mookerjee&amp;author=LM+Cheshire&amp;author=SJ+Hodges&amp;volume=10&amp;publication_year=2004&amp;pages=1109-1119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2" style=""><li><a href="#idm139814060350832title">Abstract</a></li><li><a href="#s1title">Introduction</a></li><li><a href="#s2title">Materials and Methods</a></li><li><a href="#s3title">Results</a></li><li><a href="#s4title">Discussion</a></li><li><a href="#idm139814067450256title">Funding Statement</a></li><li><a href="#idm139814060674528title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3929651/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3929651/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3929651/pdf/pone.0089230.pdf">PDF (453K)</a></li> | <li><a href="#" data-citationid="PMC3929651" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3929651%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3929651%2F&amp;text=Serum%201H-NMR%20Metabolomic%20Fingerprints%20of%20Acute-On-Chronic%20Liver%20Failure%20in%20Intensive%20Care%20Unit%20Patients%20with%20Alcoholic%20Cirrhosis" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3929651%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="24586615" data-aiid="3929651" data-aid="3929651" data-iid="233283" data-domainid="440" data-domain="plosone" data-accid="PMC3929651" data-md5="3070590a7173058435c76695a429b436">

<div>













</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-pone.0089230-Olson1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Intensive care of the patient with cirrhosis.<div class="authors">Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, Garcia-Tsao G, Kamath PS</div><div class="citation">Hepatology. 2011 Nov; 54(5):1864-72.</div><p>[<a href="/pubmed/21898477/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Olson1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Jalan1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Acute-on-chronic liver failure: pathophysiological basis of therapeutic options.<div class="authors">Jalan R, Williams R</div><div class="citation">Blood Purif. 2002; 20(3):252-61.</div><p>[<a href="/pubmed/11867872/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Jalan1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Moreau1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.<div class="authors">Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL–CLIF Consortium.</div><div class="citation">Gastroenterology. 2013 Jun; 144(7):1426-37, 1437.e1-9.</div><p>[<a href="/pubmed/23474284/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Moreau1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Sarin1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).<div class="authors">Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF</div><div class="citation">Hepatol Int. 2009 Mar; 3(1):269-82.</div><p>[<a href="/pubmed/19669378/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Sarin1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Dunn1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.<div class="authors">Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL</div><div class="citation">Chem Soc Rev. 2011 Jan; 40(1):387-426.</div><p>[<a href="/pubmed/20717559/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Dunn1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Amathieu1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis.<div class="authors">Amathieu R, Nahon P, Triba M, Bouchemal N, Trinchet JC, Beaugrand M, Dhonneur G, Le Moyec L</div><div class="citation">J Proteome Res. 2011 Jul 1; 10(7):3239-45.</div><p>[<a href="/pubmed/21568267/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Amathieu1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-MartinezGranados1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies.<div class="authors">Martínez-Granados B, Morales JM, Rodrigo JM, Del Olmo J, Serra MA, Ferrández A, Celda B, Monleón D</div><div class="citation">Int J Mol Med. 2011 Jan; 27(1):111-7.</div><p>[<a href="/pubmed/21072494/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-MartinezGranados1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Yu1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus.<div class="authors">Yu K, Sheng G, Sheng J, Chen Y, Xu W, Liu X, Cao H, Qu H, Cheng Y, Li L</div><div class="citation">J Proteome Res. 2007 Jul; 6(7):2413-9.</div><p>[<a href="/pubmed/17539670/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Yu1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Jimenez1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.<div class="authors">Jiménez B, Montoliu C, MacIntyre DA, Serra MA, Wassel A, Jover M, Romero-Gomez M, Rodrigo JM, Pineda-Lucena A, Felipo V</div><div class="citation">J Proteome Res. 2010 Oct 1; 9(10):5180-7.</div><p>[<a href="/pubmed/20690770/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Jimenez1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Qi1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Comparison of the metabolic profiling of hepatitis B virus-infected cirrhosis and alcoholic cirrhosis patients by using (1) H NMR-based metabonomics.<div class="authors">Qi S, Tu Z, Ouyang X, Wang L, Peng W, Cai A, Dai Y</div><div class="citation">Hepatol Res. 2012 Jul; 42(7):677-85.</div><p>[<a href="/pubmed/22404306/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Qi1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Qi2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis.<div class="authors">Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, Cai AJ, Dai Y</div><div class="citation">World J Gastroenterol. 2012 Jan 21; 18(3):285-90.</div><p>[<a href="/pubmed/22294833/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Qi2">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Tripathi1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">1H NMR spectroscopic study of blood serum for the assessment of liver function in liver transplant patients.<div class="authors">Tripathi P, Bala L, Saxena R, Yachha SK, Roy R, Khetrapal CL</div><div class="citation">J Gastrointestin Liver Dis. 2009 Sep; 18(3):329-36.</div><p>[<a href="/pubmed/19795028/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Tripathi1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Serkova1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Early detection of graft failure using the blood metabolic profile of a liver recipient.<div class="authors">Serkova NJ, Zhang Y, Coatney JL, Hunter L, Wachs ME, Niemann CU, Mandell MS</div><div class="citation">Transplantation. 2007 Feb 27; 83(4):517-21.</div><p>[<a href="/pubmed/17318087/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Serkova1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Saxena1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure.<div class="authors">Saxena V, Gupta A, Nagana Gowda GA, Saxena R, Yachha SK, Khetrapal CL</div><div class="citation">NMR Biomed. 2006 Aug; 19(5):521-6.</div><p>[<a href="/pubmed/16598697/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Saxena1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Dellinger1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.<div class="authors">Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee., American Association of Critical-Care Nurses., American College of Chest Physicians., American College of Emergency Physicians., Canadian Critical Care Society., European Society of Clinical Microbiology and Infectious Diseases., European Society of Intensive Care Medicine., European Respiratory Society., International Sepsis Forum., Japanese Association for Acute Medicine., Japanese Society of Intensive Care Medicine., Society of Critical Care Medicine., Society of Hospital Medicine., Surgical Infection Society., World Federation of Societies of Intensive and Critical Care Medicine.</div><div class="citation">Crit Care Med. 2008 Jan; 36(1):296-327.</div><p>[<a href="/pubmed/18158437/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Dellinger1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Vincent1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.<div class="authors">Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S</div><div class="citation">Crit Care Med. 1998 Nov; 26(11):1793-800.</div><p>[<a href="/pubmed/9824069/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Vincent1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Pugh1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Transection of the oesophagus for bleeding oesophageal varices.<div class="authors">Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R</div><div class="citation">Br J Surg. 1973 Aug; 60(8):646-9.</div><p>[<a href="/pubmed/4541913/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Pugh1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Kamath1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> A model to predict survival in patients with end-stage liver disease.<div class="authors">Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR</div><div class="citation">Hepatology. 2001 Feb; 33(2):464-70.</div><p>[<a href="/pubmed/11172350/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Kamath1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Trygg1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">19. <span class="mixed-citation">
Trygg J, Wold S (2002) <span class="ref-title">Othogonal projections to latent structure (OPLS)</span>. <span class="ref-journal">J Chemometrics</span>
<span class="ref-vol">16</span>: 116–128. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Chemometrics&amp;title=Othogonal+projections+to+latent+structure+(OPLS)&amp;author=J+Trygg&amp;author=S+Wold&amp;volume=16&amp;publication_year=2002&amp;pages=116-128&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="#pone.0089230-Trygg1">Ref list</a>]</div><div id="body-link-popper-pone.0089230-Nicholson1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma.<div class="authors">Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC</div><div class="citation">Anal Chem. 1995 Mar 1; 67(5):793-811.</div><p>[<a href="/pubmed/7762816/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Nicholson1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Wevers1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies.<div class="authors">Wevers RA, Engelke U, Heerschap A</div><div class="citation">Clin Chem. 1994 Jul; 40(7 Pt 1):1245-50.</div><p>[<a href="/pubmed/8013094/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Wevers1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Nahon1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.<div class="authors">Nahon P, Amathieu R, Triba MN, Bouchemal N, Nault JC, Ziol M, Seror O, Dhonneur G, Trinchet JC, Beaugrand M, Le Moyec L</div><div class="citation">Clin Cancer Res. 2012 Dec 15; 18(24):6714-22.</div><p>[<a href="/pubmed/23136190/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Nahon1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Cloarec1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets.<div class="authors">Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, Hudson J, Blancher C, Gauguier D, Lindon JC, Holmes E, Nicholson J</div><div class="citation">Anal Chem. 2005 Mar 1; 77(5):1282-9.</div><p>[<a href="/pubmed/15732908/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Cloarec1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Bernal1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study.<div class="authors">Bernal W, Donaldson N, Wyncoll D, Wendon J</div><div class="citation">Lancet. 2002 Feb 16; 359(9306):558-63.</div><p>[<a href="/pubmed/11867109/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Bernal1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Shangraw1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Hepatic pyruvate dehydrogenase activity in humans: effect of cirrhosis, transplantation, and dichloroacetate.<div class="authors">Shangraw RE, Rabkin JM, Lopaschuk GD</div><div class="citation">Am J Physiol. 1998 Mar; 274(3):G569-77.</div><p>[<a href="/pubmed/9530159/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Shangraw1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Rastogi1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF).<div class="authors">Rastogi A, Kumar A, Sakhuja P, Bihari C, Gondal R, Hissar S, Garg H, Sarin SK</div><div class="citation">Virchows Arch. 2011 Aug; 459(2):121-7.</div><p>[<a href="/pubmed/21744153/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Rastogi1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Ranjan1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy.<div class="authors">Ranjan P, Gupta A, Kumar S, Gowda GA, Ranjan A, Sonker AA, Chandra A, Ramakant</div><div class="citation">Liver Int. 2006 Aug; 26(6):703-7.</div><p>[<a href="/pubmed/16842327/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Ranjan1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Rosen1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Plasma amino acid patterns in hepatic encephalopathy of differing etiology.<div class="authors">Rosen HM, Yoshimura N, Hodgman JM, Fischer JE</div><div class="citation">Gastroenterology. 1977 Mar; 72(3):483-7.</div><p>[<a href="/pubmed/832796/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Rosen1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Cazzaniga1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.<div class="authors">Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F</div><div class="citation">J Hepatol. 2009 Sep; 51(3):475-82.</div><p>[<a href="/pubmed/19560225/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Cazzaniga1">Ref list</a>]</p></div><div id="body-link-popper-pone.0089230-Sen1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.<div class="authors">Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R</div><div class="citation">Liver Transpl. 2004 Sep; 10(9):1109-19.</div><p>[<a href="/pubmed/15350001/" ref="reftype=pubmed&amp;article-id=3929651&amp;issue-id=233283&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0089230-Sen1">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 64px; left: 459px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=plosone&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3929651/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 95B63906E70AD421_0000SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></htm
